Abstract:As a prevalent, life-threatening and highly recurrent psychiatric illness, depression is characterized by a wide range of pathological changes; however, its etiology remains incompletely understood. Accumulating evidence supports that gut microbiota affects not only gastrointestinal physiology but also central nervous system (CNS) function and behavior through the microbiota-gut-brain axis. To assess the impact of gut microbiota on fecal metabolic phenotype in depressive conditions, an integrated approach of 16S rRNA gene sequencing combined with ultra high-performance liquid chromatography-mass spectrometry (UHPLC-MS) based metabolomics was performed in chronic variable stress (CVS)-induced depression rat model. Interestingly, depression led to significant gut microbiota changes, at the phylum and genus levels in rats treated with CVS compared to controls. The relative abundances of the bacterial genera Marvinbryantia, Corynebacterium, Psychrobacter, Christensenella, Lactobacillus, Peptostreptococcaceae incertae sedis, Anaerovorax, Clostridiales incertae sedis and Coprococcus were significantly decreased, whereas Candidatus Arthromitus and Oscillibacter were markedly increased in model rats compared with normal controls. Meanwhile, distinct changes in fecal metabolic phenotype of depressive rats were also found, including lower levels of amino acids, and fatty acids, and higher amounts of bile acids, hypoxanthine and stercobilins. Moreover, there were substantial associations of perturbed gut microbiota genera with the altered fecal metabolites, especially compounds involved in the metabolism of tryptophan and bile acids. These results showed that the gut microbiota was altered in association with fecal metabolism in depressive conditions. These findings suggest that the 16S rRNA gene sequencing and LC-MS based metabolomics approach can be further applied to assess pathogenesis of depression.

Depression-associated gut microbes, metabolites and clinical trials

Epigenetics in depression and gut-brain axis: A molecular crosstalk

Gut microbiota and its metabolites in depression: from pathogenesis to treatment

Mood and Microbes: a Comprehensive Review of Intestinal Microbiota’s Impact on Depression

Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications

Mood and microbes: a comprehensive review of intestinal microbiota's impact on depression

Deciphering the Gut Microbiome's Influence on Depression: A Community-Level Constraint-Based Metabolic modelling Approach

Variations in Gut Microbiota and Fecal Metabolic Phenotype Associated with Depression by 16S Rrna Gene Sequencing and LC/MS-based Metabolomics.

The Microbiota–Gut–Brain Axis in Depression: The Potential Pathophysiological Mechanisms and Microbiota Combined Antidepression Effect

Probiotics for the treatment of depression and its comorbidities: A systemic review

Current landscape of fecal microbiota transplantation in treating depression

Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review

Depressed gut? The microbiota-diet-inflammation trialogue in depression

New perspectives on microbiome-dependent gut-brain pathways for the treatment of depression with gastrointestinal symptoms: from bench to bedside

Brain–gut–microbiota axis in depression: A historical overview and future directions

Human Gut Microbiota for Diagnosis and Treatment of Depression

Gut Microbiota Metabolites in Major Depressive Disorder—Deep Insights into Their Pathophysiological Role and Potential Translational Applications

Review of research progress on intestinal microbiota based on metabolism and inflammation for depression

Reviewing the role of gut microbiota in the pathogenesis of depression and exploring new therapeutic options

Research progress on intestinal flora and depression

Characteristics of gut microbiota and metabolic phenotype in patients with major depressive disorder based on multi-omics analysis